Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours.
Saved in:
| Title: | Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours. |
|---|---|
| Authors: | Cheeseman SL; CRC Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK., Brannan M, McGown A, Khan P, Gardner C, Gumbrell L, Dickens D, Ranson M |
| Source: | British journal of cancer [Br J Cancer] 2000 Dec; Vol. 83 (12), pp. 1599-606. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Print ISSN: 0007-0920 (Print) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 11104552 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cheeseman+SL%22">Cheeseman SL</searchLink>; CRC Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Brannan+M%22">Brannan M</searchLink><br /><searchLink fieldCode="AU" term="%22McGown+A%22">McGown A</searchLink><br /><searchLink fieldCode="AU" term="%22Khan+P%22">Khan P</searchLink><br /><searchLink fieldCode="AU" term="%22Gardner+C%22">Gardner C</searchLink><br /><searchLink fieldCode="AU" term="%22Gumbrell+L%22">Gumbrell L</searchLink><br /><searchLink fieldCode="AU" term="%22Dickens+D%22">Dickens D</searchLink><br /><searchLink fieldCode="AU" term="%22Ranson+M%22">Ranson M</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2000 Dec; Vol. 83 (12), pp. 1599-606. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase I; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0007-0920 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=11104552 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1054/bjoc.2000.1503 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1599 Titles: – TitleFull: Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cheeseman SL – PersonEntity: Name: NameFull: Brannan M – PersonEntity: Name: NameFull: McGown A – PersonEntity: Name: NameFull: Khan P – PersonEntity: Name: NameFull: Gardner C – PersonEntity: Name: NameFull: Gumbrell L – PersonEntity: Name: NameFull: Dickens D – PersonEntity: Name: NameFull: Ranson M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2000 Dec Type: published Y: 2000 Identifiers: – Type: issn-print Value: 0007-0920 Numbering: – Type: volume Value: 83 – Type: issue Value: 12 Titles: – TitleFull: British journal of cancer Type: main |
| ResultId | 1 |
